Start Date: 08/06/2017
End Date: 08/06/2017
Venue: Central London
Westminster Forum Projects
The future of biosimilars in the UK: regulation, access and medicines optimisation
Thursday, 8th June 2017
Guest of Honour
Dr Christian Schneider, Director, National Institute for Biological Standards and Control, MHRA
This seminar will provide the opportunity to discuss the future of biosimilar medicines in the UK.
Delegates will assess the next steps for regulation and pharmacovigilance, the impact of increased competition between originator and biosimilar manufacturers and the challenges for embedding use in service delivery following the publication of NHS England’s ‘What is a biosimilar medicine?’ guide.
Sessions will also focus on the implications of the UK vote to leave the European Union on access to biosimilars, key issues for clinicians around switching from originator to biosimilar - and the next steps for patient engagement, education and involvement.